17-7443117-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004112.4(FGF11):āc.649G>Cā(p.Ala217Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,611,726 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004112.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGF11 | NM_004112.4 | c.649G>C | p.Ala217Pro | missense_variant | 5/5 | ENST00000293829.9 | NP_004103.1 | |
FGF11 | NM_001303460.2 | c.472G>C | p.Ala158Pro | missense_variant | 5/5 | NP_001290389.1 | ||
FGF11 | NR_130156.2 | n.689G>C | non_coding_transcript_exon_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGF11 | ENST00000293829.9 | c.649G>C | p.Ala217Pro | missense_variant | 5/5 | 1 | NM_004112.4 | ENSP00000293829.4 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152044Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000801 AC: 2AN: 249694Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134954
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1459682Hom.: 0 Cov.: 29 AF XY: 0.0000220 AC XY: 16AN XY: 726228
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152044Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74250
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2023 | The c.649G>C (p.A217P) alteration is located in exon 5 (coding exon 5) of the FGF11 gene. This alteration results from a G to C substitution at nucleotide position 649, causing the alanine (A) at amino acid position 217 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at